Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

B-ABSSSI was the reason I got into IPIX in the first place years ago. I am very displeased that we could not monetize it back then. For whatever reason, we did not.

I dont think that makes it dead or worthless, just less valuable than was anticipated. Or, it was just too expensive to fund ourselves and the partnerships available didnt pay enough to muddy the deal making on potentially larger indications like OM and IBD.

All we can do is look forward and value what we have to the best of our ability. The bits and pieces we have all add up to more than $100 million imo.